Evidence map›Paper›PMID 24027194›Full record

ArticlePsycho-oncology2014

The validity of the distress thermometer in prostate cancer populations.

Suzanne K Chambers, Leah Zajdlewicz, Danny R Youlden, Jimmie C Holland, Jeff Dunn

Registry-linked trialAbstract read
In one paragraph

Article in Psycho-oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05806255 (Remote Self-Reporting of Symptoms by Patients With Palliative Care Needs), which is not on this map. Cited by 50 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05806255 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Remote Self-Reporting of Symptoms by Patients With Palliative Care Needs (RELIEF): A Mixed-Methods Implementation Study

TypeinterventionalSponsorWilliam Osler Health SystemRan2024 to 2025Enrolled600ConditionsPalliative CareArmsThe RELIEF App
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN · 2019
    Guideline
  3. Pooled it
  4. The diagnostic role of a short screening tool--the distress thermometer: a meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2014
    Pooled it
  5. Trial
  6. Evaluation of coping as a mediator of the relationship between stressful life events and cancer-related distress.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2017
    Trial
  7. Trial
  8. Distress level in newly diagnosed thyroid cancer patients and predictors of clinically significant distress.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  9. Patient experience preparing for prostate cancer radiotherapy.Technical innovations & patient support in radiation oncology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Men's sexual help-seeking and care needs after radical prostatectomy or other non-hormonal, active prostate cancer treatments.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  18. Observational
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suzanne K ChambersGriffith Health Institute, Griffith University, Brisbane, Australia; Cancer Council Queensland, Brisbane, Australia; Prostate Cancer Foundation of Australia, Sydney, Australia; Edith Cowan University, Joondalup, Australia.
Leah Zajdlewicz
Danny R Youlden
Jimmie C Holland
Jeff Dunn

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Distress Thermometer (DT) is widely recommended for screening for distress after cancer. However, the validity of the DT in men with prostate cancer and over differing time points from diagnosis has not been well examined.

methodReceiver operating characteristics analyses were used to evaluate the diagnostic accuracy of the DT compared with three commonly used standardised scales in two prospective and one cross-sectional survey of men with prostate cancer (n = 740, 189 and 463, respectively). Comparison scales included the Impact of Event Scale - Revised (IES-R, Study 1), the Hospital Anxiety and Depression Scale (HADS, Study 2) and the Brief Symptom Inventory-18 (BSI-18, Study 3).

resultsStudy 1: the DT showed good accuracy against the IES-R at all time points (area under curves (AUCs) ranging from 0.84 to 0.88) and sensitivity was high (>85%). Study 2: the DT performed well against both the anxiety and depression subscales for HADS at baseline (AUC = 0.84 and 0.82, respectively), but sensitivity decreased substantially after 12 months. Study 3: validity was high for the anxiety (AUC = 0.90, sensitivity = 90%) and depression (AUC = 0.85, sensitivity = 74%) subscales of the BSI-18 but was poorer for somatization (AUC = 0.67, sensitivity = 52%). A DT cut-off between ≥3 and ≥6 maximised sensitivity and specificity across analyses.

conclusionsThe DT is a valid tool to detect cancer-specific distress, anxiety and depression among prostate cancer patients, particularly close to diagnosis. A cut-off of ≥4 may be optimal soon after diagnosis, and for longer-term assessments, ≥3 was supported. © 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd.

Indexed as

AdultAgedAged, 80 and overAnxietyArea Under CurveDepressionHumansMaleMass ScreeningMiddle AgedProstatic NeoplasmsPsychometricsReproducibility of ResultsSensitivity and SpecificityStress, PsychologicalSurveys and Questionnairesdistress screeningdistress thermometerprostate cancerpsychosocial care

Identifiers

PMID24027194
PMCPMC4282590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.